Smith & Nephew PLC (SNN-N) Stock Predictions - Stockchase
WATCH LIST
30
Smith & Nephew PLC (SNN-N)

ON STOCKCHASE SINCE Dec 2001

orthopedic mnfctr

biotechnology/pharmaceutical

Smith & Nephew PLC

SNN-N

1 watching          
Join the Discussion

Smith & Nephew PLC (SNN-N) SAVE Apr, 22, 2019, 11:18 am

37.72 0.28 (0.72%)

What the experts are saying about SNN-N



  • All
  • Filtered
Signal Opinion Expert
COMMENT

Has owned it in the past. Primary business in orthopedics. Great company. Last quarter has been mixed. There is speculation that they are buying Boston Scientific. Valuation wise it is OK. Stryker (SYK-N) is taking leadership in the orthopedic space. Longer term he prefers Stryker (SYK-N).

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Has owned it in the past. Primary business in orthopedics. Great company. Last quarter has been mixed. There is speculation that they are buying Boston Scientific. Valuation wise it is OK. Stryker (SYK-N) is taking leadership in the orthopedic space. Longer term he prefers Stryker (SYK-N).

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$35.590
Owned Owned
No

DON'T BUY
Smith & Nephew PLC(SNN-N) 

March 21, 2018

Smith  & Nephew  or Stryker? Smith: Knows it only marginally. The options S&N were generation aren't attractive enough for him to buy. Stryker: Keep an eye on this. Their robotic surgery is cutting a strong profile in orthopedic surgeries. It's definitely becoming the market leader.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Smith  & Nephew  or Stryker? Smith: Knows it only marginally. The options S&N were generation aren't attractive enough for him to buy. Stryker: Keep an eye on this. Their robotic surgery is cutting a strong profile in orthopedic surgeries. It's definitely becoming the market leader.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$37.810
Owned Owned
No

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

August 1, 2012

(A Top Pick Aug 11/11. Up 24.13%.) Demand for discretionary medical devices has been affected by the economy. Like many European companies, the valuations are quite low and can have further upside from here.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick Aug 11/11. Up 24.13%.) Demand for discretionary medical devices has been affected by the economy. Like many European companies, the valuations are quite low and can have further upside from here.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Charles Lannon

Director o, Toron Investment Man...

Price Price
$51.430
Owned Owned
Yes

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

February 2, 2012

(A Top Pick Feb 23/11. Down 10.95%.) Medical devices. Just reported strong numbers. Volumes in replacement knees has suffered because of the economy but still likes this long-term because of demographic tailwinds. Strong possibility it will get taken out in 3-4 years by one of its competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Feb 23/11. Down 10.95%.) Medical devices. Just reported strong numbers. Volumes in replacement knees has suffered because of the economy but still likes this long-term because of demographic tailwinds. Strong possibility it will get taken out in 3-4 years by one of its competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Charles Lannon

Director o, Toron Investment Man...

Price Price
$50.600
Owned Owned
Yes

BUY
Smith & Nephew PLC(SNN-N) 

November 29, 2011

Wounds (bandages), arthroscopic surgery and orthopedics. They are the largest presence in Europe, which is hurting them. A lot of people have lost their healthcare coverage and is hurting the industry. Ultimately this stock will do well.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Wounds (bandages), arthroscopic surgery and orthopedics. They are the largest presence in Europe, which is hurting them. A lot of people have lost their healthcare coverage and is hurting the industry. Ultimately this stock will do well.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$43.810
Owned Owned
Unknown

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

November 22, 2011

(A Top Pick Nov 19/10. Down 2.76%.) Economic environment has taken some of the wind out of their sails but they'll come back.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Nov 19/10. Down 2.76%.) Economic environment has taken some of the wind out of their sails but they'll come back.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Karl Berger

Partner, Toron Investment Man...

Price Price
$44.030
Owned Owned
Yes

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

August 30, 2011

(Top Pick Nov 10/10, Up 2.12%) knee replacements, demographic play. Last year and a half have not been that robust because knee replacements are a little bit elective. There is a pent up demand for this kind of surgery. Some interest in the space from some of their competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Top Pick Nov 10/10, Up 2.12%) knee replacements, demographic play. Last year and a half have not been that robust because knee replacements are a little bit elective. There is a pent up demand for this kind of surgery. Some interest in the space from some of their competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Karl Berger

Partner, Toron Investment Man...

Price Price
$48.950
Owned Owned
Yes

TOP PICK
Smith & Nephew PLC(SNN-N) 

August 11, 2011

(London Stock exchange.) Medical devices. This sort of business that can continue to grow a respective of the economy. Good price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(London Stock exchange.) Medical devices. This sort of business that can continue to grow a respective of the economy. Good price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Charles Lannon

Director o, Toron Investment Man...

Price Price
$0.010
Owned Owned
Yes

TOP PICK
Smith & Nephew PLC(SNN-N) 

February 23, 2011

Medical device manufacturer for replacement hips and knees. Huge demographic area. Not particularly expensive at less than 15X earnings. Strong balance sheet. Could be a takeout candidate.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Medical device manufacturer for replacement hips and knees. Huge demographic area. Not particularly expensive at less than 15X earnings. Strong balance sheet. Could be a takeout candidate.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Charles Lannon

Director o, Toron Investment Man...

Price Price
$57.730
Owned Owned
Yes

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

February 11, 2011

(A Top Pick Jan 5/10. Up 16.75%.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Jan 5/10. Up 16.75%.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Karl Berger

Partner, Toron Investment Man...

Price Price
$58.470
Owned Owned
Yes

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

November 29, 2010

(A Top Pick Dec 29/09. Down 7.58%.) Still a Buy.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Dec 29/09. Down 7.58%.) Still a Buy.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$46.250
Owned Owned
Yes

TOP PICK
Smith & Nephew PLC(SNN-N) 

November 19, 2010

Valuation is closer to $60. Likes the demographics for hip and knee replacements. Took a bit of a dip through 2008-2009 as the economy contracted.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Valuation is closer to $60. Likes the demographics for hip and knee replacements. Took a bit of a dip through 2008-2009 as the economy contracted.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Karl Berger

Partner, Toron Investment Man...

Price Price
$46.910
Owned Owned
Yes

PAST TOP PICK
Smith & Nephew PLC(SNN-N) 

August 10, 2010

(A Top Pick June 12/09. Up 18.92%.) Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick June 12/09. Up 18.92%.) Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Charles Lannon

Director o, Toron Investment Man...

Price Price
$45.880
Owned Owned
Yes

PAST TOP PICK
(A Top Pick May 8/08. Up 38.71%.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick May 8/08. Up 38.71%.)
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$48.230
Owned Owned
Unknown

TOP PICK
Smith & Nephew PLC(SNN-N) 

January 5, 2010

Knee replacements. Nicely situated within this industry. Aging population will create a demand.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Knee replacements. Nicely situated within this industry. Aging population will create a demand.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Karl Berger

Partner, Toron Investment Man...

Price Price
$50.580
Owned Owned
Yes

Showing 1 to 15 of 30 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days